Suppr超能文献

来自墨西哥利什曼原虫lmcpb基因阵列破坏的证据表明,半胱氨酸蛋白酶是毒力因子。

Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors.

作者信息

Mottram J C, Souza A E, Hutchison J E, Carter R, Frame M J, Coombs G H

机构信息

Wellcome Unit of Molecular Parasitology, University of Glasgow, Scotland, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6008-13. doi: 10.1073/pnas.93.12.6008.

Abstract

The mammalian form of the protozoan parasite Leishmania mexicana contains high activity of a cysteine proteinase (LmCPb) encoded on a tandem array of 19 genes (lmcpb). Homozygous null mutants for lmcpb have been produced by targeted gene disruption. All life-cycle stages of the mutant can be cultured in vitro, demonstrating that the gene is not essential for growth or differentiation of the parasite. However, the mutant exhibits a marked phenotype affecting virulence-- its infectivity to macrophages is reduced by 80%. The mutants are as efficient as wild-type parasites in invading macrophages but they only survive in a small proportion of the cells. However, those parasites that successfully infect these macrophages grow normally. Despite their reduced virulence, the mutants are still able to produce subcutaneous lesions in mice, albeit at a slower rate than wild-type parasites. The product of a single copy of lmcpb re-expressed in the null mutant was enzymatically active and restored infectivity toward macrophages to wild-type levels. Double null mutants created for lmcpb and lmcpa (another cathepsin L-like cysteine proteinase) have a similar phenotype to the lmcpb null mutant, showing that LmCPa does not compensate for the loss of LmCPb.

摘要

原生动物寄生虫墨西哥利什曼原虫的哺乳动物形式含有一种半胱氨酸蛋白酶(LmCPb)的高活性,该酶由19个基因(lmcpb)的串联阵列编码。通过靶向基因破坏产生了lmcpb的纯合无效突变体。突变体的所有生命周期阶段都可以在体外培养,这表明该基因对于寄生虫的生长或分化不是必需的。然而,该突变体表现出一种影响毒力的明显表型——其对巨噬细胞的感染性降低了80%。突变体在侵入巨噬细胞方面与野生型寄生虫一样有效,但它们仅在一小部分细胞中存活。然而,那些成功感染这些巨噬细胞的寄生虫生长正常。尽管其毒力降低,但突变体仍能够在小鼠中产生皮下病变,尽管速度比野生型寄生虫慢。在无效突变体中重新表达的单拷贝lmcpb的产物具有酶活性,并将对巨噬细胞的感染性恢复到野生型水平。为lmcpb和lmcpa(另一种组织蛋白酶L样半胱氨酸蛋白酶)创建的双无效突变体具有与lmcpb无效突变体相似的表型,表明LmCPa不能补偿LmCPb的缺失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b3/39179/58d01bd708d2/pnas01513-0346-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验